| |
Latest 10 SEC filings (by transaction date) for LXRX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 13/24 | Mar 13/24 | Artal International S.C.A. | Indirect Ownership | Series A Convertible Preferred Stock | A - Grant, award or other under Rule 16b-3(d) | 1,150,922 | $108.50 |
Feb 29/24 | Feb 28/24 | Alexander Kristen | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -15,927 | |
Feb 29/24 | Feb 28/24 | Alexander Kristen | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -10,616 | |
Feb 29/24 | Feb 28/24 | Alexander Kristen | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -2,700 | |
Feb 29/24 | Feb 28/24 | Alexander Kristen | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -11,793 | $2.62 |
Feb 29/24 | Feb 28/24 | Alexander Kristen | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 15,927 | |
Feb 29/24 | Feb 28/24 | Alexander Kristen | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 10,616 | |
Feb 29/24 | Feb 28/24 | Alexander Kristen | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 2,700 | |
Feb 29/24 | Feb 28/24 | Wade Jeffrey L | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -49,113 | |
Feb 29/24 | Feb 28/24 | Wade Jeffrey L | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -37,274 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for LXRX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 13/24 | Mar 13/24 | Artal International S.C.A. | Indirect Ownership | Series A Convertible Preferred Stock | A - Grant, award or other under Rule 16b-3(d) | 1,150,922 | $108.50 |
Feb 29/24 | Feb 28/24 | Alexander Kristen | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -15,927 | |
Feb 29/24 | Feb 28/24 | Alexander Kristen | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -10,616 | |
Feb 29/24 | Feb 28/24 | Alexander Kristen | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -2,700 | |
Feb 29/24 | Feb 28/24 | Alexander Kristen | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -11,793 | $2.62 |
Feb 29/24 | Feb 28/24 | Alexander Kristen | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 15,927 | |
Feb 29/24 | Feb 28/24 | Alexander Kristen | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 10,616 | |
Feb 29/24 | Feb 28/24 | Alexander Kristen | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 2,700 | |
Feb 29/24 | Feb 28/24 | Wade Jeffrey L | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -49,113 | |
Feb 29/24 | Feb 28/24 | Wade Jeffrey L | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -37,274 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |